PRAX FY 2023 Earnings — Praxis Precision Medicines, Inc. Revenue & Financial Results | Market Cap Arena

PRAXPraxis Precision Medicines, Inc.

$7B

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M

Gross Profit

-$84M-3445.8% margin

Operating Income

-$126M-5164.4% margin

Net Income

-$123M-5037.9% margin

EPS (Diluted)

$-18.69

Cash Flow

Operating Cash Flow

-$111M

Free Cash Flow

-$111M

Stock-Based Comp.

$25M

Balance Sheet

Total Assets

$88M

Total Liabilities

$18M

Stockholders' Equity

$70M

Cash & Equivalents

$81M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$0	—
Gross Profit	-$84M	-$154M	+45.4%
Operating Income	-$126M	-$215M	+41.2%
Net Income	-$123M	-$214M	+42.4%